Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Key Research Highlights Triple GLP-1, GIP, and glucagon receptor activity Metabolic pathway and energy expenditure research Appetite and satiety signaling studies Hepatic lipid metabolism investigations Cardiovascular biomarker research Frequently studied alongside MOTS-c Research Applications of Retatrutide Retatrutide has emerged as one of the most promising compounds in metabolic research due to its unique ability to activate GLP-1, GIP, and glucagon receptors simultaneously
Future research will explore novel pathways and expand therapeutic applications
It is not FDA-approved for treating any condition
Final Notes The conversation around covering GLP-1 medications for weight loss is growing, and employers are grappling with the costs and benefits
US$ 29.35
US$ 22.65
US$ 27.65
US$ 24.19
US$ 28.65
US$ 26.27
